Program overview
Context
Indication: Acute Myeloid Leukemia
Mechanism: Unknown
Modality: Unknown
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Venetoclax+Decitabine is flagged as timeline staleness signal because public records show timeline staleness. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Acute Myeloid Leukemia
Mechanism: Unknown
Modality: Unknown
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Registry: 1/5
Timeline: 3/5
Recruitment burden: 0/5
Results availability: 0/5
Program risk: 2/5
https://clinicaltrials.gov/study/NCT04763928
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT04763928 | Low Signal (ACTIVE_NOT_RECRUITING) | stale_update_signal | primary_completion_date_past_signal | long_recruitment_duration_signal | Low Signal | None |